• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by NICE Ltd

    5/15/25 7:51:59 AM ET
    $NICE
    Computer Software: Prepackaged Software
    Technology
    Get the next $NICE alert in real time by email
    6-K 1 zk2533209.htm 6-K


    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C.  20549

    FORM 6-K

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13A-16 OR 15D-16 OF
    THE SECURITIES EXCHANGE ACT OF 1934

    For the month of May 2025 (Report No. 2)

    Commission File Number: 0-27466

    NICE LTD.

    (Translation of Registrant’s Name into English)
     

    13 Zarchin Street, P.O. Box 690, Ra’anana 4310602, Israel

    (Address of Principal Executive Offices)
     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
     
    Form 20-F ☒ Form 40-F ☐
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
     

    THE GAAP FINANCIAL STATEMENTS ATTACHED TO THE PRESS RELEASE ATTACHED HERETO AS EXHIBIT 99.1 OF THIS REPORT ON FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO NICE LTD.`S (“NICE”) REGISTRATION STATEMENTS ON FORM S-8 (REGISTRATION STATEMENT NOS. 333-166364, 333-168100, 333-171165, 333-162795, 333-162110, 333-06784, 333-08146, 333-11842, 333-09350, 333-11154, 333-111112, 333-111113, 333-134355, 333-144589, 333-145981, 333-153230, 333-177510, 333-179408, 333-181375, 333-191176, 333-199904, 333-210341, 333-210343, 333-210344, 333-214584, 333-226930, 333-228911, 333-249186 and 333-270969), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
     
    CONTENTS
     
    This Report on Form 6-K of NICE consists of the following documents, which are attached hereto and incorporated by reference herein:
     
    99.1          Press Release: NICE Reports 12% Year-Over-Year Cloud Revenue Growth for the First Quarter 2025 and Raises Full-Year 2025 EPS Guidance, Dated May 15, 2025.
     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


    NICE LTD.  

         

    By:
    /s/ Noa Farkas Gluck  

    Name:
    Noa Farkas Gluck  

    Title:   
    Head of Corporate Legal  

     
    Dated: May 15, 2025
     

    EXHIBIT INDEX

    99.1
    Press Release: NICE Reports 12% Year-Over-Year Cloud Revenue Growth for the First Quarter 2025 and Raises Full-Year 2025 EPS Guidance, Dated May 15, 2025.
     

    Get the next $NICE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NICE

    DatePrice TargetRatingAnalyst
    1/17/2025$176.00Neutral
    Cantor Fitzgerald
    12/19/2024$215.00 → $200.00Buy → Hold
    Jefferies
    11/15/2024Outperform → Perform
    Oppenheimer
    11/14/2024Overweight → Neutral
    Piper Sandler
    4/23/2024$285.00Buy
    Rosenblatt
    3/13/2024$250.00 → $300.00Neutral → Buy
    DA Davidson
    1/30/2024$300.00Outperform
    Northland Capital
    10/16/2023$225.00 → $220.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings